117 related articles for article (PubMed ID: 20707992)
1. Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients.
Lacchini R; Jacob-Ferreira AL; Luizon MR; Coeli FB; Izidoro-Toledo TC; Gasparini S; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
Clin Chim Acta; 2010 Dec; 411(23-24):1940-4. PubMed ID: 20707992
[TBL] [Abstract][Full Text] [Related]
2. Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients.
Lacchini R; Jacob-Ferreira AL; Luizon MR; Gasparini S; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
J Hum Hypertens; 2012 Mar; 26(3):171-7. PubMed ID: 21307882
[TBL] [Abstract][Full Text] [Related]
3. The rs243866/243865 polymorphisms in MMP-2 gene and the relationship with BP control in obese resistant hypertensive subjects.
Ritter AMV; de Faria AP; Barbaro NR; Sabbatini AR; Corrêa NB; Brunelli V; Fattori A; Amorim R; Modolo R; Moreno H
Gene; 2018 Mar; 646():129-135. PubMed ID: 29288728
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.
Sabbatini AR; Barbaro NR; de Faria AP; Ritter AMV; Modolo R; Correa NB; Brunelli V; Pinho C; Fontana V; Moreno H
Gene; 2017 Jul; 620():23-29. PubMed ID: 28390988
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children.
Belo VA; Souza-Costa DC; Luizon MR; Lanna CM; Carneiro PC; Izidoro-Toledo TC; Ferraz KC; Tanus-Santos JE
Int J Obes (Lond); 2012 Jan; 36(1):69-75. PubMed ID: 21844877
[TBL] [Abstract][Full Text] [Related]
6. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
8. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.
Gai X; Lan X; Luo Z; Wang F; Liang Y; Zhang H; Zhang W; Hou J; Huang M
Clin Chim Acta; 2009 Oct; 408(1-2):105-9. PubMed ID: 19665460
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects.
Metzger IF; Luizon MR; Lacchini R; Tanus-Santos JE
DNA Cell Biol; 2012 Apr; 31(4):504-10. PubMed ID: 21936677
[TBL] [Abstract][Full Text] [Related]
10. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.
Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M
Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860
[TBL] [Abstract][Full Text] [Related]
11. The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension.
Wang X; Yang X; Sun K; Chen J; Song X; Wang H; Liu Z; Wang C; Zhang C; Hui R
Clin Sci (Lond); 2009 Oct; 118(2):137-45. PubMed ID: 19505289
[TBL] [Abstract][Full Text] [Related]
12. Negative association of endothelial nitric oxide gene polymorphism with hypertension in Turkish patients: effect of ecNOS polymorphism on left ventricular hypertrophy.
Olcay A; Ekmekci CG; Ozbek U; Sezer M; Barcin C; Arslan E; Boztosun B; Nisanci Y
Cardiovasc Ultrasound; 2006 Aug; 4():33. PubMed ID: 16923191
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects.
Demacq C; Vasconcellos VB; Marcaccini AM; Gerlach RF; Silva WA; Tanus-Santos JE
Clin Chem Lab Med; 2008; 46(1):57-63. PubMed ID: 18194081
[TBL] [Abstract][Full Text] [Related]
14. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
15. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
[TBL] [Abstract][Full Text] [Related]
16. Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects.
Luizon MR; Belo VA; Fernandes KS; Andrade VL; Tanus-Santos JE; Sandrim VC
Mol Biol Rep; 2016 Jun; 43(6):463-71. PubMed ID: 27146834
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
Pharmacogenomics J; 2012 Dec; 12(6):489-98. PubMed ID: 21769110
[TBL] [Abstract][Full Text] [Related]
18. Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients.
Oceandy D; Yusoff R; Baudoin FM; Neyses L; Ray SG
Eur J Heart Fail; 2007 Oct; 9(10):1010-7. PubMed ID: 17765638
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy.
Vasconcellos V; Lacchini R; Jacob-Ferreira AL; Sales ML; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
DNA Cell Biol; 2010 Apr; 29(4):171-6. PubMed ID: 20070154
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension.
Xue H; Wang S; Wang H; Sun K; Song X; Zhang W; Fu C; Han Y; Hui R
Clin Sci (Lond); 2008 Jan; 114(2):131-7. PubMed ID: 17672826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
